Prospective registry for recording surgical treatment of benign prostatic hyperplasia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039041

Enrollment

2000

Registered

2026-01-20

Start date

2026-02-23

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N40

Interventions

Group 1: Male, aged 18 or over, patients undergoing holmium laser enucleation/thulium laser enucleation (HoLEP/ThuLEP) for benign prostatic hyperplasia. During the BPH surgery, the surgical/patient d

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients undergoing holmium/thulium laser enucleation of the prostate due to benign prostatic hyperplasia (BPH)

Exclusion criteria

Exclusion criteria: Persons incapable of giving consent

Design outcomes

Primary

Measure	Time frame
- Type of surgery - Equipment used (laser and morcellator) - Duration of use (laser and morcellation) - Duration of surgery - Materials used -Results from examinations and patient data (prostate size, PSA, perioperative complications, pathology results, preoperative medication)	—

Countries

Germany

Contacts

Public ContactAlexander Winter

Universitätsklinik für Urologie

winter.alexander@klinikum-oldenburg.de+49 441 403 2302

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026